Ledger.Open graph →
SEC Form D · filed July 31, 2020

AzurRx BioPharma, Inc

Offering
$22.8M
Sold
$22.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BROOKLYN, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Vern L. Schramm · Brooklyn, NYDirectorCharles Casamento · Brooklyn, NYDirectorJames Sapirstein · Brooklyn, NYExec · DirectorJames L. Pennington · Brooklyn, NYExecEdward Borkowski · Brooklyn, NYDirectorDaniel Schneiderman · Brooklyn, NYExecAlastair Riddell · Brooklyn, NYDirectorAaron Olson · Madison, WIDirectorBill Radvak · Vancouver, British Columbia, CanadaExecMichael Simpson · Denver, CODirectorJoon Hyuk Heo · New York, NYDirectorGerald Mcmorrow · KIRKLAND, WADirectorTahsinul Z. Huque · BROOKLYN, NYExeca Delaware limited liability company Goat Rodeo Capital GP II, LLC · San Francisco, CAExec · DirectorGregory Oakes · Brooklyn, NYDirectorMichael Munoz · Toronto, Ontario, CanadaDirectorKathleen S. Goin · Wayne, PADirectorScott H. Morenstein · Wayne, PADirectorAdam Towvim · Auburndale, MAExecTerrance R. Ahern · Cleveland, OHDirectorDavid Iannarone · WASHINGTON, Washington, D.C.ExecPeter Smith · WASHINGTON, Washington, D.C.Exec · DirectorGregory Oakes · Brooklyn, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗